Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
Clinical trial NCT07604233 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07604233
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-30
- Primary completion
- 2031-06-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.